课题基金 / 基金详情

Thyrocyte protein transport to the cell surface

Thyrocyte protein transport to the cell surface
甲状腺细胞蛋白质转运至细胞表面
批准号:
9462701
负责人:
PETER ARVAN
金额:
$49.05万
依托单位国家:
美国
项目类别:
财政年份:
1988
资助国家:
美国
项目状态:
已结题
起止时间:
1988-09-01 至 2020-03-31

项目摘要

项目成果

PETER ARVAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This grant concentrates on endoplasmic reticulum (ER) protein misfolding and ER stress-induced endocrine cell death, using the thyroid gland as a model. Diseases of this kind affect every organ system. The thyroid is an ideally-suited model system in which to study this problem because, unlike the situation in pancreatic beta cells (in which compromised insulin production leads to a vicious cycle of detrimental effects on beta cell survival caused by glucoliptoxicity), when thyroid hormone production is compromised, the hypothyroidism itself does not itself limit compensatory thyroid gland expansion. Normally, the thyroid gland synthesizes thyroid hormone, which is essential for control of metabolism, development, and brain function. A limited number of selectively-expressed thyroid gene products are involved in thyroid hormone production, including thyroglobulin (Tg). The thyroid can devote up to 50% of total protein synthesis to this one protein. Cells such as thyrocytes have a "supercharged" protein secretion pathway with tonic "physiological ER stress". At least 50 Tg mutations are responsible for autosomal recessive congenital hypothyroidism - all of these produce proteins entrapped within the ER. Many Tg mutations are associated with goiter, but for others, compensatory expansion of the thyroid gland is blocked. We hypothesize that for the latter group of Tg mutants, proteotoxic thyroid cell death limits compensatory tissue expansion. In this application, we provide new mechanistic data supporting this hypothesis, highlighting the thyroid gland as the best in vivo system available in which to study ER stress-mediated endocrine cell failure. Quantifying cell death is straightforward in the thyroid system, and importantly, the loss of compensatory tissue expansion can be easily followed in real time, noninvasively, in living animals. Our Specific Aims for the next 5 years are: 1. To define region-dependent effects of the Tg protein on its transport and proteotoxicity; 2. To explore in vivo therapies that facilitate cell survival in the face of ER overload (from misfolded Tg); and 3. To exploit Tgn-/- mice to examine classical ER stress response in thyroid cell death, and to uncover a previously unidentified precursor protein for T4 synthesis.
期刊论文(36)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1210/jc.2009-2109
发表时间: 2010-06
期刊: The Journal of clinical endocrinology and metabolism
影响因子: --
作者: [D. Peteiro-González;Jaemin Lee;J. Rodriguez-Fontan;Isabel Castro-Piedras;J. Cameselle-Teijeiro;Andrés Beiras;Susana B. Bravo;Clara V. Alvarez;D. Hardy;H. Targovnik;Peter Arvan;J. Lado-Abeal]
通讯作者: D. Peteiro-González;Jaemin Lee;J. Rodriguez-Fontan;Isabel Castro-Piedras;J. Cameselle-Teijeiro;Andrés Beiras;Susana B. Bravo;Clara V. Alvarez;D. Hardy;H. Targovnik;Peter Arvan;J. Lado-Abeal
Disulfide-linked aggregation of thyroglobulin normally occurs during nascent protein folding.
甲状腺球蛋白的二硫键连接聚集通常发生在新生蛋白质折叠过程中。
DOI: 10.1152/ajpcell.1993.265.3.c704
发表时间: 1993
期刊: The American journal of physiology
影响因子: --
作者: [Kim,PS, Kim,KR, Arvan,P]
通讯作者: Arvan,P
DOI: 10.1210/edrv.19.2.0327
发表时间: 1998-04
期刊: Endocrine reviews
影响因子: 20.3
作者: [P. Kim;P. Arvan]
通讯作者: P. Kim;P. Arvan
Thyroglobulin is selected as luminal protein cargo for apical transport via detergent-resistant membranes in epithelial cells.
甲状腺球蛋白被选为管腔蛋白货物,通过上皮细胞中的耐去污剂膜进行顶端运输。
DOI: 10.1074/jbc.m005429200
发表时间: 2000
期刊: The Journal of biological chemistry
影响因子: --
作者: [Martin-Belmonte,F, Alonso,MA, Zhang,X, Arvan,P]
通讯作者: Arvan,P
13
    Improving Proinsulin Folding to Ameliorate Type II Diabetes
    Endoplasmic Reticulum stress and thyroid cell death
    Endoplasmic Reticulum stress and thyroid cell death
    A Stress-Induced Vicious Cycle In The Development of T1D
    海外基金